SHOCKWAVE MEDICAL INC (SWAV) Stock Overview
USA - NASDAQ:SWAV - US82489T1043 - Common Stock
SWAV Key Statistics, Chart & Performance
The current stock price of SWAV is 334.75 USD. In the past month the price increased by 1.49%. In the past year, price increased by 15.77%.
SWAV Latest News, Press Relases and Analysis
SWAV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.42 | 220.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.47 | 195.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.27 | 149.82B | ||
| SYK | STRYKER CORP | 29.71 | 145.96B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.02 | 53.26B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.61 | 44.68B | ||
| RMD | RESMED INC | 27.17 | 37.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 35.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.26 | 27.76B | ||
| DXCM | DEXCOM INC | 41.37 | 27.58B |
Related stock screener links
About SWAV
Company Profile
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
Company Info
SHOCKWAVE MEDICAL INC
5403 Betsy Ross Dr
Santa Clara CALIFORNIA 95054 US
CEO: Douglas Godshall
Employees: 1001
Phone: 15102794262
SHOCKWAVE MEDICAL INC / SWAV FAQ
What does SWAV do?
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
What is the stock price of SHOCKWAVE MEDICAL INC today?
The current stock price of SWAV is 334.75 USD. The price decreased by -0.02% in the last trading session.
Does SWAV stock pay dividends?
SWAV does not pay a dividend.
What is the ChartMill technical and fundamental rating of SWAV stock?
SWAV has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is SHOCKWAVE MEDICAL INC (SWAV) stock traded?
SWAV stock is listed on the Nasdaq exchange.
How is the market expecting SWAV stock to perform?
16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.
SWAV Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SWAV. When comparing the yearly performance of all stocks, SWAV is one of the better performing stocks in the market, outperforming 87.72% of all stocks.
SWAV Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SWAV. SWAV is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
SWAV Financial Highlights
Over the last trailing twelve months SWAV reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 12.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.76% | ||
| ROA | 9.95% | ||
| ROE | 21.76% | ||
| Debt/Equity | 0.97 |
SWAV Forecast & Estimates
16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.
For the next year, analysts expect an EPS growth of 36.11% and a revenue growth 27.69% for SWAV